to assess the bioavailability of a new oral and slow release form of isosorbide dinitrate ( isdn-sr ) , we evaluated 12 patients with confirmed coronary artery disease , chronic stable angina pectoris and abnormal maximal exercise tests ( angina-limited and associated with greater than or equal to 0.1 mv st displacement ) .
C0022252
isosorbide
C0002962
angina